AUS
NZ
UK
CA
USA
IND
Healthcare
Solventum (NYSE:SOLV) Expands Healthcare Portfolio Amid Market Developments
March 24, 2026 05:02 PM PDT| By Anmol KhazanchiThe healthcare sector continues to evolve through innovation, regulatory shifts, and changing patient needs, with companies focusing on specialized solutions that address clinical and operational challenges.
Johnson And Johnson (NYSE:JNJ) Targets Oncology Growth Through New Trial Russell 1000
March 24, 2026 02:34 PM PDT| By Anmol KhazanchiJohnson and Johnson operates within the global healthcare sector, spanning pharmaceuticals, medical devices, and consumer health offerings. The company maintains a broad research base.
Steris Plc (NYSE:STE) Valuation Perspective And Stock Movement Across S&P 500
March 24, 2026 01:32 PM PDT| By Anmol KhazanchiThe healthcare equipment and sterilization services sector plays a critical role in global medical infrastructure, supporting hospitals, laboratories, and pharmaceutical facilities with infection prevention solutions.
PTC Therapeutics (NASDAQ:PTCT) Gains Attention After Rating Updates
March 24, 2026 08:57 AM PDT| By Anmol KhazanchiPTC Therapeutics (NASDAQ:PTCT) highlights biotech sector activity, institutional engagement, and valuation movement within Nasdaq composite trends.
Soleno Therapeutics (NASDAQ:SLNO) Moves With Broader Nasdaq Index Decline
March 24, 2026 07:56 AM PDT| By Anmol KhazanchiSoleno Therapeutics (NASDAQ:SLNO) reaches a new low while maintaining strong liquidity and institutional participation within Nasdaq index trends.
Eli Lilly (NYSE:LLY) Sees Institutional Activity in Russell 1000
March 24, 2026 04:36 AM PDT| By Anmol KhazanchiEli Lilly in the russell 1000 highlights institutional trends, expanding drug pipelines, and evolving healthcare demand influencing pharmaceutical operations across global markets and therapeutic segments.
Shoulder Innovations (NYSE:SI) And Medline Healthcare Manufacturing Driving Better Care
March 23, 2026 05:31 PM PDT| By Anmol KhazanchiThe healthcare manufacturing sector plays a critical role in supporting clinical environments through the development and distribution of essential medical products. Companies operating in this space focus on delivering tools, devices.
Penumbra Inc (NYSE:PEN) Devices Makes Waves Across Russell 1000 Healthcare Stocks
March 23, 2026 03:28 PM PDT| By Anmol KhazanchiPenumbra operates within the healthcare and medical device sector, delivering advanced solutions designed for vascular and neurovascular conditions. The company develops technologies used in hospitals.
Cardinal Health (NYSE:CAH) Strengthens Global Network For Russell 1000 Etf Watchers
March 23, 2026 02:45 PM PDT| By Anmol KhazanchiThe healthcare distribution sector plays a vital role in ensuring that essential medical products reach hospitals, pharmacies, and clinical facilities efficiently. Within this sector.
Medtronic's (NYSE:MDT) Global Reach Shapes Healthcare Innovation Across The S&P 500
March 23, 2026 01:28 PM PDT| By Anmol KhazanchiThe global healthcare and medical technology sector plays a vital role in advancing patient care through innovative devices, diagnostic tools, and therapeutic systems. Companies operating within this space focus on improving clinical outcomes.
CONMED (NYSE:CNMD) Strengthens Role In Nyse Composite Landscape
March 23, 2026 11:04 AM PDT| By Anmol KhazanchiCONMED Corporation (NYSE:CNMD) provides surgical technologies for minimally invasive procedures, with global operations and market activity reflecting its presence within the NYSE Composite.
Does Janux Therapeutics (NASDAQ:JANX) Show Signs of Market Sensitivity?
March 23, 2026 08:17 AM PDT| By Anmol KhazanchiJanux Therapeutics (NASDAQ:JANX) reflects market focus through rating updates, institutional activity, and biotech pipeline progress within Nasdaq today trends.
AbbVie (NYSE:ABBV) Shares Rise on Revenue Growth, S&P 500 Gains
March 23, 2026 05:17 AM PDT| By Anmol KhazanchiAbbVie (NYSE:ABBV) delivers specialty medicines across immunology, oncology, neuroscience, and women’s health, with strategic collaborations and reporting practices positioning it within the s&p 500 chart.
Is Repligen (NASDAQ:RGEN) Influenced By Nasdaq Index Volatility?
March 23, 2026 12:00 AM PDT| By Anmol KhazanchiRepligen Corporation (NASDAQ:RGEN) gains attention after brokerage revisions, strong financial performance, and positioning within Nasdaq index trends.
Does Viking Therapeutics (NASDAQ:VKTX) Show Stability In The Nasdaq 100 Index?
March 23, 2026 12:00 AM PDT| By Anmol KhazanchiViking Therapeutics (NASDAQ:VKTX) sees continued rating support, institutional activity, and valuation focus within Nasdaq 100 index trends.
Is Mirum Pharmaceuticals (NASDAQ:MIRM) Stabilizing After Rating Updates?
March 23, 2026 12:00 AM PDT| By Anmol KhazanchiMirum Pharmaceuticals (NASDAQ:MIRM) sees rating updates, institutional activity, and valuation focus within Nasdaq composite dynamics.
Zimmer Biomet (NYSE:ZBH) Reflects Activity In S&P 500 Fund Segment
March 23, 2026 12:00 AM PDT| By Anmol KhazanchiZimmer Biomet (NYSE:ZBH) provides global musculoskeletal medical technologies, with operations and market presence aligned with companies tracked in the S&P 500 fund.
Boston Scientific (NYSE:BSX) Falls as Recall Draws S&P 500 Focus
March 22, 2026 09:12 AM PDT| By Anmol KhazanchiBoston Scientific’s role in the s&p 500 highlights medical device advancements, regulatory developments, and evolving healthcare trends influencing global treatment technologies and industry dynamics.
Abbott (NYSE:ABT) Expands Diagnostics With Exact Sciences Amid S&P 500 Futures
March 20, 2026 02:55 PM PDT| By Anmol KhazanchiThe healthcare sector continues to evolve through strategic consolidation, particularly in diagnostics and chronic disease management. Abbott Laboratories operates across medical devices, diagnostics, nutrition.
Conmed (NYSE:CNMD) Portfolio Changes Reflect Broader Market Trends Nyse Composite Today
March 20, 2026 02:46 PM PDT| By Anmol KhazanchiThe medical device sector is shaped by innovation in surgical tools, minimally invasive procedures, and hospital efficiency demands. Companies in this space often adjust their product portfolios to align with evolving clinical practices.
